Description

Pletol (cilostazol) tablets 50 mg. №60

Ingredients:

Each tablet contains 50 mg of cilostazol.

Dosage:

The recommended dosage is one tablet (50 mg) taken orally twice daily, at least half an hour before or two hours after breakfast and dinner.

Indications:

Pletol (cilostazol) is indicated for the treatment of intermittent claudication. It helps improve walking distance in patients with this condition.

Contraindications:

Do not use Pletol if you have heart failure of any severity. Consult your healthcare provider before starting this medication.

Directions:

Take Pletol exactly as prescribed by your doctor. Do not change the dosage or stop the medication without consulting your healthcare provider.

Scientific Evidence:

Studies have shown that cilostazol, the active ingredient in Pletol, effectively improves walking distance and symptoms in patients with intermittent claudication. Research published in the Journal of Vascular Surgery demonstrated the efficacy of cilostazol in increasing pain-free walking distance and improving quality of life in these patients.

Additional Information:

It is important to follow a comprehensive treatment plan that may include exercise, diet, and smoking cessation in addition to taking Pletol. Regular follow-up with your healthcare provider is essential to monitor your progress and adjust the treatment if needed.

Cilostazol, the active ingredient in Pletol, is a phosphodiesterase inhibitor that works by widening blood vessels and increasing blood flow to the legs. This helps reduce the symptoms of intermittent claudication, such as leg pain and cramping during physical activity.

Compared to other medications used for intermittent claudication, cilostazol has shown comparable effectiveness with a favorable side effect profile. It is well-tolerated by most patients and has been a valuable addition to the treatment options for this condition.